Welcure Drugs & Pharmaceuticals share news, announcements and annual reports
BSE: 524661Pharmaceuticals & BiotechnologySmall Cap
Welcure Drugs & Pharmaceuticals ltd · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1994
Last close ₹0.18₹0.00 (0.00%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹0.18.
30 Oct: open ₹0.18, high ₹0.19, low ₹0.17
52-week range of traded prices to 30 Oct 2026
₹0.17Low, 23 Oct 2026₹0.64High, 13 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹22 Cr3,646th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 86,46,796
Welcure Drugs & Pharmaceuticals board meetings
130 filed, newest first. Page 1 of 3.
Jul 2026
Jun 2026
19 Jun · Board meeting
Meeting on 19 Jun 2026
May 2026
22 May · Board meeting
Meeting on 29 May 2026: audited results
Feb 2026
9 Feb · Board meeting
Meeting on 12 Feb 2026: quarterly results
Dec 2025
1 Dec · Board meeting
Meeting on 5 Dec 2025: rights issue of equity shares
Nov 2025
27 Nov · Board meeting
Meeting on 1 Dec 202510 Nov · Board meeting
Meeting on 13 Nov 2025: quarterly results
Oct 2025
17 Oct · Board meeting
Meeting on 17 Oct 202517 Oct · Board meeting
Sep 2025
27 Sep · Board meeting
25 Sep · Board meeting
Meeting on 27 Sep 2025
Aug 2025
28 Aug · Board meeting
Meeting on 2 Sep 2025: annual general meeting28 Aug · Board meeting
22 Aug · Board meeting
20 Aug · Board meeting
Meeting on 28 Aug 202511 Aug · Board meeting
Meeting on 22 Aug 2025: bonus issue and stock split
Jul 2025
31 Jul · Board meeting
Meeting on 5 Aug 2025: quarterly results
May 2025
29 May · Board meeting
20 May · Board meeting
Meeting on 29 May 2025: audited results9 May · Board meeting
Meeting on 14 May 2025: increase in authorised capital
Feb 2025
10 Feb · Board meeting
Meeting on 14 Feb 2025: quarterly results
Jan 2025
Dec 2024
2 Dec · Board meeting
Meeting on 2 Dec 2024
Nov 2024
7 Nov · Board meeting
Meeting on 14 Nov 2024: quarterly results
Oct 2024
21 Oct · Board meeting